A 12 week, Phase 2A, Randomized, Subject and Investigator Blinded, Placebo-Controlled Trial to Evaluate the Safety, Tolerability and Efficacy of CE-326,597
|Effective start/end date
|2/26/08 → 12/31/08
- PFIZER, INC.
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.